PRTODAY / NewswireToday Free press release distribution service network

More news: Software
Written by / Agency / Source: Kenexa | IBM

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

IBM and Illumina Partner to Standardize Genomic Data Interpretation - Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017 [NASDAQ: ILMN] - Illumina.com / IBM.com
IBM and Illumina Partner to Standardize Genomic Data Interpretation

 

NewswireToday - /newswire/ - San Francisco, CA, United States, 2017/01/09 - Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017 [NASDAQ: ILMN] - Illumina.com / IBM.com. NASDAQ: KNXA

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

IBM Watson Health and Illumina, Inc. today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace® Sequence Hub and tumor sequencing process. The collaboration is designed to help standardize and simplify genomic data interpretation.

By adding Watson for Genomics to Illumina’s next-generation sequencing platform, researchers who use Illumina’s cancer genome sequencing panel will have rapid access to information to help interpret the broad array of variant data produced by TruSight Tumor 170. Illumina’s TruSight® Tumor 170 is a solid tumor profiling panel designed to detect a comprehensive set of variants across 170 genes.

In a matter of minutes, Watson for Genomics will read the genetic alteration files produced by TruSight Tumor 170, comb professional guidelines, medical literature, clinical trials compendia, and other sources of knowledge to provide information for each genomic alteration, and produce a report for use by researchers -- a process that typically takes scientists more than one week to complete. Watson for Genomics ingests data from approximately 10,000 scientific articles and 100 new clinical trials every month.

The Watson for Genomics software will be available to support Illumina’s TruSight Tumor 170 assay early in 2017.

Cancer is a leading cause of death worldwide and a growing body of research shows that analyzing the genomic basis of a tumor can be important for understanding the individual patient’s disease, a major aspect of precision medicine. However, the output of next generation sequencing panels requires sophisticated analyses to help identify the mutations responsible for cancer growth and correlate that information with potential standard and experimental treatment options. This is where Watson is expected to help.

“To enable precision cancer medicine on a large scale, we need new tools to overcome the data barriers of genomic research,” said Francis deSouza, President and CEO of Illumina.. “With a comprehensive assay of Illumina and the power of Watson, we hope to deliver a rapid turnaround of the genomic alteration results.”

Genome sequencing has increased in recent years following two decades of research demonstrating the promise of precision medicine. However, access to these advances has been limited by the significant time and expense required to interpret the genomic data.

“This partnership lays the groundwork for more systematic study of the impact of genomics in oncology,” said Deborah DiSanzo, general manager, IBM Watson Health. “Together we are poised to help researchers realize the potential of precision oncology by expanding access to valuable genome sequencing from Illumina and reliable, standardized genomic interpretation from Watson.”

For Research Use Only. Not for use in diagnostic procedures.

About IBM Watson Health
Watson (ibm.com/watsonhealth) is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions. In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform. The new unit helps improve the ability of doctors, researchers and insurers to innovate by surfacing insights from the massive amount of personal health data being created and shared daily. The Watson Health Cloud can mask patient identities and allow for information to be shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

About Illumina
Illumina (illumina.com) is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Contact: Jen Carroll - Illumina Media Relations
P: 858-882-6822 - E: pr[.]illumina.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kenexa | IBM

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


IBM and Illumina Partner to Standardize Genomic Data Interpretation

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Christine Douglass - IBM.com 
415-535-4479 cgdouglass[.]us.ibm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kenexa | IBM securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kenexa | IBM / Company Profile


Read Software Most Recent Related Newswires:

MyoKardia Reduces VM Backup Budget by 50% with NAKIVO
Infor Achieves FedRAMP Ready Status
Cortland Capital Market Services, LLC Adopts Yardi Investment Management
JDRF and IBM Collaborate to Research Risk Factors for Type 1 Diabetes in Children
MasterControl Unveils New Corporate Headquarters
The Weather Company, an IBM Business, to Integrate Global Flight Tracking Data from FlightAware
ROLI Harmonizes its Global Business with NetSuite OneWorld
Independent Research Firm Recognizes Hexaware as A Strong Performer in Continuous Testing Providers’ Evaluation
Airbus Selects OneLogin
Higher Education Institutions Select Oracle EPM Cloud to Drive Student Success
Splunk Introduces Splunk Insights for AWS Cloud Monitoring
HSBC and IBM Develop Cognitive Intelligence Solution to Digitise Global Trade
New Absolute 7 Platform Extends Endpoint Visibility and Control, Enabling Enterprises to See, Manage and Secure Every Endpoint, Everywhere
Sony and Sony Global Education Develop a New System to Manage Students' Learning Data, Built on IBM Blockchain
Oracle Empowers Organizations to Meet Accelerating Market Changes with Major Innovations to Supply Chain Management Cloud

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  S&A Capital Partner Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)